ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Nutriband Inc

Nutriband Inc (NTRB)

4.82
-0.16
( -3.21% )
Actualizado: 10:33:44

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
4.82
Postura de Compra
4.80
Postura de Venta
4.99
Volume Operado de la Acción
5,198
4.71 Rango del Día 5.14
2.22 Rango de 52 semanas 9.595
Capitalización de Mercado [m]
Precio Anterior
4.98
Precio de Apertura
4.91
Última hora de negociación
10:33:44
Volumen financiero
US$ 25,100
Precio Promedio Ponderado
4.8288
Volumen promedio (3 m)
32,287
Acciones en circulación
11,096,185
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-9.65
Beneficio por acción (BPA)
-0.49
turnover
2.09M
Beneficio neto
-5.49M

Acerca de Nutriband Inc

Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically O... Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products. Mostrar más

Sector
Ortho,prosth,surg Appl,suply
Industria
Ortho,prosth,surg Appl,suply
Sitio web
Sede
Las Vegas, Nevada, USA
Fundado
-
Nutriband Inc is listed in the Ortho,prosth,surg Appl,suply sector of the NASDAQ with ticker NTRB. The last closing price for Nutriband was US$4.98. Over the last year, Nutriband shares have traded in a share price range of US$ 2.22 to US$ 9.595.

Nutriband currently has 11,096,185 shares in issue. The market capitalisation of Nutriband is US$55.26 million. Nutriband has a price to earnings ratio (PE ratio) of -9.65.

NTRB Últimas noticias

IBN Coverage Initiated for Nutriband Inc.

LOS ANGELES, April 25, 2024 (GLOBE NEWSWIRE) -- via IBN – Nutriband Inc. (NASDAQ: NTRB), a pharmaceutical company with a specific focus on transdermal technologies, today announces it has...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.06-1.229508196724.885.144.64119614.90215226CS
4-0.99-17.03958691915.816.44.63170635.4204418CS
120.378.314606741574.458.493.75322875.8701832CS
26-0.03-0.6185567010314.859.5953.75330296.02021717CS
522.52109.5652173912.39.5952.22314625.0177159CS
156-1.51-23.85466034766.3312.181.532646289.12233085CS
260-0.66-12.04379562045.4812.321.533632359.12530357CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
WORXSCWorx Corporation
US$ 2.0002
(104.10%)
109.68M
CRNCCerence Inc
US$ 4.83
(71.28%)
34.81M
IBGInnovation Beverage Group Limited
US$ 1.135
(43.45%)
8.84M
QUBTQuantum Computing Inc
US$ 5.0514
(37.27%)
90.59M
SPAISafe Pro Group Inc
US$ 4.2701
(33.44%)
38.86M
GLXGGalaxy Payroll Group Ltd
US$ 1.68
(-57.03%)
892.74k
PYXSPyxis Oncology Inc
US$ 2.07
(-45.81%)
9.55M
KURAKura Oncology Inc
US$ 10.08
(-36.64%)
7.96M
BLRXBioLineRx Ltd
US$ 0.3545
(-34.98%)
6.17M
SHOTWSafety Shot Inc
US$ 0.1001
(-33.27%)
2.5k
CDTConduit Pharmaceuticals Inc
US$ 0.111001
(20.26%)
496.04M
NVDANVIDIA Corporation
US$ 145.1021
(-0.54%)
205.78M
AKTSAkoustis Technologies Inc
US$ 0.1003
(15.15%)
184.24M
ELABElevai Labs Inc
US$ 0.0202
(-5.61%)
174.72M
WORXSCWorx Corporation
US$ 2.0002
(104.10%)
108.78M

NTRB Discussion

Ver más
Seriously folks Seriously folks 4 meses hace
Must have been an interesting webinar….double the volume and down 8%.
👍️0
Monksdream Monksdream 4 meses hace
NTRB new 52 week high
👍️0
Seriously folks Seriously folks 6 meses hace
Now I’m told “it’ll “ happen 4q 2025….
More baloney….
👍️0
Seriously folks Seriously folks 6 meses hace
Now I’m told “it’ll “ happen 4q 2025….
More baloney….
👍️0
Seriously folks Seriously folks 6 meses hace
Typical ntrb day…
👍️0
Awl416 Awl416 6 meses hace
Solid day
👍️0
Monksdream Monksdream 7 meses hace
Wowser! I happen to agree with you.
👍️0
ZigZag1 ZigZag1 7 meses hace
It’s under $5 for a reason. Management is just using this company as a lifestyle paycheck.
👍️0
Monksdream Monksdream 7 meses hace
NTRB under $5

👍️0
Monksdream Monksdream 8 meses hace
NTRB under $5
👍️0
glenn1919 glenn1919 8 meses hace
NTRB................................https://stockcharts.com/h-sc/ui?s=NTRB&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 8 meses hace
NTRB....MONSTER
👍️0
TrendTrade2016 TrendTrade2016 8 meses hace
NTRB...GAPPING INTO OPEN FOR THE SELL
👍️0
glenn1919 glenn1919 8 meses hace
NTRB...................................https://stockcharts.com/h-sc/ui?s=NTRB&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 8 meses hace
NTRB....PRE TO OPEN BEAST
👍️0
Inve$tor77 Inve$tor77 11 meses hace
$NTRB 2.95. Nice buys.
👍️0
ZigZag1 ZigZag1 1 año hace
This will be at a $1.50 by the end of the week. Management sure sold me on this one!
👍️0
ZigZag1 ZigZag1 1 año hace
You’d think it price would reflect news like this. They have to get rid of the word “fentanyl”. It’s so toxic. It’s right up there with ephedrine and OxyContin.
👍️0
Inve$tor77 Inve$tor77 1 año hace
Nice news!

https://www.accesswire.com/785775/nutriband-announces-issuance-of-us-patent-for-transdermal-abuse-deterrent-technology
👍️0
ZigZag1 ZigZag1 1 año hace
I sold everything, I just check back from time to time. I think they are now just using their money for salaries. Their model has the word “fentanyl” in it which is about as toxic as the word “OxyContin”.
👍️0
Seriously folks Seriously folks 1 año hace
What’s going on with this stock?
👍️0
McMagyar McMagyar 1 año hace
Ollie Ollie unkenfraz
👍️0
McMagyar McMagyar 1 año hace
What lurks behind the curtain!
👍️0
stock1ace1 stock1ace1 1 año hace
Registration withdraw low float
👍️0
Monksdream Monksdream 1 año hace
NTRB dead cat and the down trend resumes?
👍️0
Inve$tor77 Inve$tor77 1 año hace
What’s with the huge selling? Seems like big ask
👍️0
Inve$tor77 Inve$tor77 1 año hace
Bid and ask tight. Volume coming in.
👍️0
Inve$tor77 Inve$tor77 1 año hace
Agreed. Once the selling stop perhaps it will rebound back .
👍️0
ZigZag1 ZigZag1 1 año hace
It could. But being out of money is going to make things tough. They definitely need something good to happen for this to pop.
👍️0
Inve$tor77 Inve$tor77 1 año hace
I’m not sure it’s going to hit that low before a nice bounce back. It’s still a low float stock.
👍️0
ZigZag1 ZigZag1 1 año hace
I personally see it at $1. Their revenue comes from k tape that you can get off of Amazon for $5. Their hope is this fentanyl patch. But even if they get approval? I don’t see many Drs wanting to prescribe it, nor patients wanting it. Let’s put it this way; if a dr asked you if you wanted traditional pain meds or a fentanyl patch; what would you want?
👍️0
Inve$tor77 Inve$tor77 1 año hace
Where’s bottom? Should be close for a bounce hopefully.
👍️0
ZigZag1 ZigZag1 1 año hace
It’s like 7.5m outstanding, but now doing an offering of $4m with a market cap of $15m, just simply means they are out of money. This isn’t looking good. I just wish they would change the name to something like “drug deterrent patch” or something. Who would want to keep an investment in fentanyl? That’s a word right up there with OxyContin???
👍️0
Inve$tor77 Inve$tor77 1 año hace
Wasn’t there an offering for $4 mill minus underwriting fees?
I don’t remember the volume being that high. Isn’t that around 1.5 million shares sold.

“Our common stock is traded on the NASDAQ Capital Market under the symbol “NTRB. On June 22, 2023, the last reported sale price of our common stock was $2.48 per share.”
👍️0
ZigZag1 ZigZag1 1 año hace
Dang, they get a patent approved and now it’s tanking. This will give you an idea of how solid their model is.
👍️0
ZigZag1 ZigZag1 1 año hace
Why so much volume today?
👍️0
Inve$tor77 Inve$tor77 1 año hace
New 52 week lows geez. What’s going on?
👍️0
Inve$tor77 Inve$tor77 1 año hace
$2.50s. Looking for a nice bounce possibly . Float is tiny
👍️0
ZigZag1 ZigZag1 1 año hace
I’m not sure their model has the capability of meaningful good news. Anything with the fentanyl in it, proves to be an uphill battle.
👍️0
Inve$tor77 Inve$tor77 1 año hace
With any good news or buying pressure this can take off nicely. Very thin float.
👍️0
Inve$tor77 Inve$tor77 1 año hace
Nice bounce recovery from lows. When good news hits looking forward to a big climb. I saw they filed for a small offering a couple of weeks ago. I’m surprised they did it at this low price.
👍️0
ZigZag1 ZigZag1 1 año hace
Yes they are. But I think it’s going to be an up-hill battle trying to get anything approved with the word “Fentanyl” in it. Talk about FDA scrutiny!
👍️0
Inve$tor77 Inve$tor77 1 año hace
Does anyone know if they are still waiting on FDA approval ?
👍️0
McMagyar McMagyar 2 años hace
Nice day
👍️0
Seriously folks Seriously folks 2 años hace
It looks like this might be turning around….
👍️0
McMagyar McMagyar 3 años hace
Entrepreneurial spirit isn’t dead
Nutriband full steam ahead
👍️0
McMagyar McMagyar 3 años hace
I don’t think market is giving the 3m agreement enough value.they may have a few surprises coming our way
👍️0
Seriously folks Seriously folks 3 años hace
Still heading the wrong direction!
👍️0
Seriously folks Seriously folks 3 años hace
What a disappointment……
👍️0
StocksNcash StocksNcash 3 años hace
I dumped it garbage
👍️0

Su Consulta Reciente

Delayed Upgrade Clock